Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study

Gow, Chien-HungChien-HungGowMIN-SHU HSIEHChen, Yi-LinYi-LinChenLiu, Yi-NanYi-NanLiuSHANG-GIN WUJIN-YUAN SHIH2023-04-202023-04-2020232234-943Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/630362The MET exon 14 skipping (METex14) mutation is an important oncogenic driver in lung cancer. We performed a retrospective analysis of clinical data from lung cancer patients with the METex14 mutation to analyze their survival outcomes and associated prognostic factors.enMET exon 14 skipping; adenocarcinoma; immunohistochemistry; overall survival; pulmonary sarcomatoid carcinomaSurvival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world studyjournal article10.3389/fonc.2023.1113696369690592-s2.0-85150656958WOS:000952069900001https://api.elsevier.com/content/abstract/scopus_id/85150656958